Latest Insider Transactions at Jazz Pharmaceuticals PLC (JAZZ)
This section provides a real-time view of insider transactions for Jazz Pharmaceuticals PLC (JAZZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Jazz Pharmaceuticals plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Jazz Pharmaceuticals plc's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 06
2021
|
Kenneth W O'Keefe Director |
SELL
Open market or private sale
|
Direct |
1,306
-6.24%
|
$191,982
$147.96 P/Share
|
Aug 06
2021
|
Norbert G Riedel Director |
SELL
Open market or private sale
|
Direct |
1,306
-11.16%
|
$191,982
$147.96 P/Share
|
Aug 06
2021
|
Catherine A. Sohn Director |
SELL
Open market or private sale
|
Direct |
1,306
-10.15%
|
$191,982
$147.96 P/Share
|
Aug 06
2021
|
Rick E Winningham Director |
SELL
Open market or private sale
|
Direct |
1,306
-15.47%
|
$191,982
$147.96 P/Share
|
Aug 05
2021
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,652
+0.85%
|
$121,992
$46.83 P/Share
|
Aug 05
2021
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-3.79%
|
$146,964
$148.49 P/Share
|
Aug 05
2021
|
Paul L Berns Director |
SELL
Open market or private sale
|
Direct |
1,450
-14.89%
|
$223,300
$154.0 P/Share
|
Aug 05
2021
|
Elmar Schnee Director |
SELL
Open market or private sale
|
Direct |
1,632
-16.48%
|
$251,328
$154.0 P/Share
|
Aug 02
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,750
-0.28%
|
$295,750
$169.99 P/Share
|
Jul 29
2021
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+31.71%
|
-
|
Jul 29
2021
|
Patrick G Enright Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+9.03%
|
-
|
Jul 29
2021
|
Peter Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+13.6%
|
-
|
Jul 29
2021
|
Heather Ann Mc Sharry Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+15.15%
|
-
|
Jul 29
2021
|
Seamus Mulligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+0.19%
|
-
|
Jul 29
2021
|
Kenneth W O'Keefe Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+9.7%
|
-
|
Jul 29
2021
|
Anne O Riordan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+18.78%
|
-
|
Jul 29
2021
|
Norbert G Riedel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+16.1%
|
-
|
Jul 29
2021
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+31.71%
|
-
|
Jul 29
2021
|
Catherine A. Sohn Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+14.86%
|
-
|
Jul 29
2021
|
Rick E Winningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,246
+21.01%
|
-
|
Jul 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,850
-3.39%
|
$1,953,000
$180.67 P/Share
|
Jun 05
2021
|
Kim Sablich EVP, GM of U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,452
-5.73%
|
$255,552
$176.47 P/Share
|
Jun 05
2021
|
Robert Iannone EVP, Global Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,206
-3.98%
|
$212,256
$176.47 P/Share
|
Jun 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,750
-0.54%
|
$313,250
$179.07 P/Share
|
May 05
2021
|
Christopher J. Tovey EVP, COO & Managing Director E |
BUY
Grant, award, or other acquisition
|
Direct |
9,091
+49.93%
|
-
|
May 05
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
500
-0.16%
|
$85,000
$170.0 P/Share
|
May 03
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-0.46%
|
$246,000
$164.24 P/Share
|
Apr 05
2021
|
Renee D Gala President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,515
-5.64%
|
$248,460
$164.71 P/Share
|
Apr 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-0.46%
|
$246,000
$164.96 P/Share
|
Mar 09
2021
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
961
-13.72%
|
$154,721
$161.5 P/Share
|
Mar 08
2021
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,089
-13.45%
|
$175,329
$161.61 P/Share
|
Mar 08
2021
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
1,509
-8.37%
|
$242,949
$161.6 P/Share
|
Mar 05
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,516
-6.21%
|
$3,528,624
$164.75 P/Share
|
Mar 05
2021
|
Robert Iannone EVP, Global Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
741
-2.4%
|
$121,524
$164.75 P/Share
|
Mar 05
2021
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
691
-2.57%
|
$113,324
$164.75 P/Share
|
Mar 05
2021
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,402
-10.49%
|
$229,928
$164.75 P/Share
|
Mar 05
2021
|
Daniel N Swisher Jr President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,718
-6.93%
|
$609,752
$164.75 P/Share
|
Mar 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
9,600
-2.7%
|
$1,632,000
$170.0 P/Share
|
Feb 25
2021
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,590
+50.0%
|
-
|
Feb 25
2021
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,590
+50.0%
|
-
|
Feb 25
2021
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,895
+18.97%
|
-
|
Feb 25
2021
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,925
+9.63%
|
-
|
Feb 25
2021
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+27.35%
|
-
|
Feb 25
2021
|
Robert Iannone EVP, Global Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
8,535
+21.65%
|
-
|
Feb 25
2021
|
Finbar Larkin SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,950
+17.97%
|
-
|
Feb 25
2021
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,270
+21.31%
|
-
|
Feb 25
2021
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,160
+19.13%
|
-
|
Feb 25
2021
|
Kim Sablich EVP, GM of U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
8,535
+25.2%
|
-
|
Feb 25
2021
|
Daniel N Swisher Jr President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
11,695
+17.89%
|
-
|
Feb 03
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
250
-0.08%
|
$40,000
$160.0 P/Share
|